Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial

Peer Review reports

Original Submission
4 Sep 2020	Submitted	Original manuscript
4 Sep 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
8 Sep 2020	Editorially accepted
26 Oct 2020	Article published	10.1186/s13063-020-04734-z

Back to article page